Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000488357 | SCV000575262 | uncertain significance | not provided | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Invitae | RCV003517202 | SCV004299200 | uncertain significance | Lethal multiple pterygium syndrome | 2023-10-24 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 137 of the CHRNA1 protein (p.Thr137Met). This variant is present in population databases (rs780391418, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with CHRNA1-related conditions. ClinVar contains an entry for this variant (Variation ID: 425235). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CHRNA1 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Clinical Molecular Genetics Laboratory, |
RCV000781968 | SCV000920423 | uncertain significance | Epilepsy | 2016-09-06 | no assertion criteria provided | clinical testing | |
Clinical Molecular Genetics Laboratory, |
RCV000781969 | SCV000920424 | uncertain significance | Seizure | 2016-09-06 | no assertion criteria provided | clinical testing |